13-METHYL-2,3,4,5,6,7,8,9,10,11-DECAHYDRO-1,13-BENZOTHIAZACYCLOPENTADECIN-12(13H)-ONE
UNII S3C1L57PTN

Substance Identification & Data

This profile provides standardized clinical and technical data for 13-methyl-2,3,4,5,6,7,8,9,10,11-decahydro-1,13-benzothiazacyclopentadecin-12(13h)-one, uniquely identified by the FDA Unique Ingredient Identifier (UNII) S3C1L57PTN.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 73674-15-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

S3C1L57PTN

CAS Registry Number

73674-15-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

13-METHYL-2,3,4,5,6,7,8,9,10,11-DECAHYDRO-1,13-BENZOTHIAZACYCLOPENTADECIN-12(13H)-ONE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C18H27NOS

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

VVODFAQRGJTZOB-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

338729

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

CN1c2c(cccc2)SCCCCCCCCCCC1=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 13-methyl-2,3,4,5,6,7,8,9,10,11-decahydro-1,13-benzothiazacyclopentadecin-12(13h)-one. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.